Browse Data and Analysis

As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.

The impact of the COVID-19 on the Israeli hotel, restaurant, and institutional (HRI) sector was nothing short of devastating. According to the Israeli Central Bureau of Statistics, accommodation and foodservice activities declined by forty percent in 2020. The sector started to recover during 2021, and it is expected to recover, with a return to pre-COVID-19 sales by 2023.

With over 1,800 facilities, the Israeli food processing sector is an important player in the domestic economy.